Rheumatoid Arthritis and Diabetes: Reducing Cardiovascular Risk
Abatacept treatment resulted in a greater reduction in CVD risk compared with TNF inhibitors in patients with RA.
The realization that IL-6 is implicated in many pathologic features of RA has prompted the search for IL-6-blocking agents as therapeutic options for this condition.
Maternal RA exposure in utero may increase the risk for certain chronic conditions, including RA, thyroid disease, and epilepsy.
Investigators sought to determine which characteristics are predictive of remission induction and subsequent loss of remission in patients with moderately active RA.